The recommended dose is one tablet daily. Uses of Activella and femhrt Estrogen is used to treat hot flushes in women who are experiencing menopause. Various brands of estrogen are also used to treat vaginal dryness, itching, or burning, or to prevent o...

在今天越來越緊張世界裡, 婦女的數量遭受掉頭發增加。我們全部想要看我們最佳並且對婦女的` 加冠的榮耀的損傷' 可能是獨特地弄翻的苦惱。 掉頭發在婦女能一般看橫跨頭皮, 沒有確定禿頭補釘。如果...

Hormone therapy (HT) is used to relieve one or more menopausal symptoms caused by declining estrogen conjugated estrogens  a mixture of the sodium salts of the sulfate esters of estrone and equilin, having the actions and uses of estrogens. esterified estrogens  a ...

Business EditorsMORRIS PLAINS, N.J.--(BUSINESS WIRE)--Jan. 19, 2000Warner-Lambert Company (NYSE:WLA) today reported that diluted earnings per share increased 38 percent on a 16 percent sales gain -- 19 percent at constant foreign exchange rates -- for the fourth qua...

Hormone therapy (HT) is used to relieve one or more menopausal symptoms caused by declining estrogen levels. These symptoms may include hot flashes, night sweats and vaginal and urinary tract changes. HT can be either estrogen alone or include a progestogen (either pr...

On page 868 of the October issue a name was misspelled; the correct name is Brian S. Alper. ...

Parke-Davis has begun an "Early Experience" outreach program for its new continuous combined hormone replacement therapy, femhrt (norethindrone acetate and ethinyl estradiol tablets), which recently was approved by the Food and Drug Administration. The progr...

Barr Laboratories said it was sued by Pfizer over a challenge to the patent protecting Pfizer's hormone replacement therapy FemHrt (norethindrone acetate, 1 mg and ethinyl estradiol, 5 mcg) from generic competition. The drug has annual sales of approximately $43 milli...

Pfizer Inc. plans to divest the FemHRT, Loestrin, and Estrostep women's health product lines, saying the businesses fall ... ...

Barr Pharmaceuticals received tentative approval from the FDA for norethindrone acetate and ethinyl estradiol tablets USP, 1 mg/0.005 mg, the generic version of Warner Chilcott's Femhrt. Barr anticipates receiving final approval and launching its version of Femhrt in ...